LianBio ADR Price To Book vs. Shares Outstanding

LIANDelisted Stock  USD 2.18  0.05  2.24%   
Considering LianBio ADR's profitability and operating efficiency indicators, LianBio ADR may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess LianBio ADR's ability to earn profits and add value for shareholders.
For LianBio ADR profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LianBio ADR to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LianBio ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LianBio ADR's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LianBio ADR over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between LianBio ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if LianBio ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LianBio ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

LianBio ADR Shares Outstanding vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining LianBio ADR's current stock value. Our valuation model uses many indicators to compare LianBio ADR value to that of its competitors to determine the firm's financial worth.
LianBio ADR is rated below average in price to book category among its peers. It is rated second overall in shares outstanding category among its peers creating about  708,145,478  of Shares Outstanding per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LianBio ADR's earnings, one of the primary drivers of an investment's value.

LianBio Shares Outstanding vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

LianBio ADR

P/B

 = 

MV Per Share

BV Per Share

 = 
0.15 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

LianBio ADR

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
108.06 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

LianBio Shares Outstanding Comparison

LianBio ADR is currently under evaluation in shares outstanding category among its peers.

LianBio ADR Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in LianBio ADR, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LianBio ADR will eventually generate negative long term returns. The profitability progress is the general direction of LianBio ADR's change in net profit over the period of time. It can combine multiple indicators of LianBio ADR, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. Lianbio ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.

LianBio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on LianBio ADR. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LianBio ADR position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LianBio ADR's important profitability drivers and their relationship over time.

Use LianBio ADR in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LianBio ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will appreciate offsetting losses from the drop in the long position's value.

LianBio ADR Pair Trading

LianBio ADR Pair Trading Analysis

The ability to find closely correlated positions to LianBio ADR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LianBio ADR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LianBio ADR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LianBio ADR to buy it.
The correlation of LianBio ADR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LianBio ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LianBio ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LianBio ADR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your LianBio ADR position

In addition to having LianBio ADR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rentals Thematic Idea Now

Rentals
Rentals Theme
Companies providing rental and leasing services to public and business. The Rentals theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity